UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 237

Sortiert nach

Tailoring anti-TNF therapy in IBD: drug levels and disease activity

Nature reviews. Gastroenterology & hepatology, 2014-04, Vol.11 (4), p.243

2014

Volltextzugriff (PDF)

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management

Journal of Crohn's & colitis, 2017-01, Vol.11 (1), p.3-25

2017

Volltextzugriff (PDF)

One Size Does Not Fit All: The Case for Translational Medicine

Rambam Maimonides medical journal, 2019-04, Vol.10 (2), p.1

Chowers, Yehuda

2019

Volltextzugriff (PDF)

Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (2), p.482-494

2022

Volltextzugriff (PDF)

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

Journal of Crohn's & colitis, 2012-12, Vol.6 (10), p.965-990

2012

Volltextzugriff (PDF)

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

Gut, 2012-02, Vol.61 (2), p.241-247

2012

Volltextzugriff (PDF)

Accuracy of Capsule Colonoscopy in Detecting Colorectal Polyps in a Screening Population

Gastroenterology (New York, N.Y. 1943), 2015-05, Vol.148 (5), p.948-957.e2

2015

Volltextzugriff (PDF)

Development of the Crohn's disease digestive damage score, the Lémann score

Inflammatory bowel diseases, 2011-06, Vol.17 (6), p.1415-1422

2011

Volltextzugriff (PDF)

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience

Inflammatory bowel diseases, 2017-03, Vol.23 (3), p.404-408

2017

Volltextzugriff (PDF)

Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis

Cell reports (Cambridge), 2018-09, Vol.24 (12), p.3296-3311.e6

2018

Volltextzugriff (PDF)

Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process

The American journal of gastroenterology, 2012-12, Vol.107 (12), p.1770-1776

2012

Volltextzugriff (PDF)

The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target

Scientific reports, 2017-04, Vol.7 (1), p.715-715, Article 715

2017

Volltextzugriff (PDF)

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects

Journal of Crohn's and colitis, 2010-10, Vol.4 (4), p.355-366

2010

Volltextzugriff (PDF)

Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort study

The lancet. Gastroenterology & hepatology, 2019-07, Vol.4 (7), p.519-528

2019

Volltextzugriff (PDF)

The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression

Neoplasia (New York, N.Y.), 2017-03, Vol.19 (3), p.175-184

2017

Volltextzugriff (PDF)

Intratumoral HLA-DR−/CD33+/CD11b+ Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Frontiers in oncology, 2020-08, Vol.10, p.1375-1375

2020

Volltextzugriff (PDF)

Adalimumab Level in Breast Milk of a Nursing Mother

Clinical gastroenterology and hepatology, 2010-05, Vol.8 (5), p.475-476

2010

Volltextzugriff (PDF)

Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience

Digestive and liver disease, 2019-01, Vol.51 (1), p.68-74

2019

Volltextzugriff (PDF)

Optimizing anti-TNF treatments in inflammatory bowel disease

Autoimmunity reviews, 2014-01, Vol.13 (1), p.24-30

2014

Volltextzugriff (PDF)

Taking Crohn's disease personally

Rambam Maimonides medical journal, 2013-04, Vol.4 (2), p.e0011

Chowers, Yehuda

2013

Volltextzugriff (PDF)

Scanning Electron Microscopy of Cells and Tissues under Fully Hydrated Conditions

Proceedings of the National Academy of Sciences - PNAS, 2004-03, Vol.101 (10), p.3346-3351

2004

Volltextzugriff (PDF)

The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?

Expert review of gastroenterology & hepatology, 2015-09, Vol.9 (sup1), p.27-34

2015

Volltextzugriff (PDF)

Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn’s disease

Therapeutic advances in gastroenterology, 2016-09, Vol.9 (5), p.655-663

2016

Volltextzugriff (PDF)

Significance of low level infliximab in the absence of anti-infliximab antibodies

World journal of gastroenterology : WJG, 2015-02, Vol.21 (6), p.1907-1914

2015

Volltextzugriff (PDF)

Efficacy of anti-TNF in Crohn's disease: how does it work?

Current drug targets, 2010-02, Vol.11 (2), p.138

2010

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(217)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(152)
Humans
(132)
Gastroenterology & Hepatology
(99)
Female
(66)
Male
(66)
Adult
(62)
Middle Aged
(48)
Crohn's Disease
(44)
Gastroenterology And Hepatology
(37)
Inflammatory Bowel Disease
(33)
Biological And Medical Sciences
(29)
Ulcerative Colitis
(29)
Inflammatory Bowel Diseases - Drug Therapy
(28)
Young Adult
(27)
Infliximab
(26)
Medical Sciences
(25)
Aged
(24)
Crohn Disease - Drug Therapy
(23)
Adolescent
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tailoring anti-TNF therapy in IBD: drug levels and disease activity

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management

One Size Does Not Fit All: The Case for Translational Medicine

Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

Accuracy of Capsule Colonoscopy in Detecting Colorectal Polyps in a Screening Population

Development of the Crohn's disease digestive damage score, the Lémann score

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience

Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis

Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process

The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects

Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort study

The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression

Intratumoral HLA-DR−/CD33+/CD11b+ Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Adalimumab Level in Breast Milk of a Nursing Mother

Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience

Optimizing anti-TNF treatments in inflammatory bowel disease

Taking Crohn's disease personally

Scanning Electron Microscopy of Cells and Tissues under Fully Hydrated Conditions

The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?

Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn’s disease

Significance of low level infliximab in the absence of anti-infliximab antibodies

Efficacy of anti-TNF in Crohn's disease: how does it work?

Suchergebnisse filtern